| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-06 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-06 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.2 | 0.0003 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0003 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.0004 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.14 | 0.001 |